Filed Sept. 22, 2021

Serial No. 97040402

Examining Attorney JACQUELINE GEBHARDT

Class Drug delivery agents in hypercompressed solid dosage form for implantation under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in hypercompressed solid dosage form for injection under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in hypercompressed solid dosage form for inhalation or taken orally or placed on the skin for local absorption through the skin, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for implantation under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for injection under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for inhalation or taken orally or placed on the skin for local absorption through the skin, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark